AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome.
Levenga J, Hayashi S, de Vrij FM, Koekkoek SK, van der Linde HC, Nieuwenhuizen I, Song C, Buijsen RA, Pop AS, Gomezmancilla B, Nelson DL, Willemsen R, Gasparini F, Oostra BA.
Levenga J, et al. Among authors: buijsen ra.
Neurobiol Dis. 2011 Jun;42(3):311-7. doi: 10.1016/j.nbd.2011.01.022. Epub 2011 Feb 21.
Neurobiol Dis. 2011.
PMID: 21316452